Quintiles and Invivodata, Inc. have entered a collaboration agreement for patient reported outcomes (PRO) solutions and services for global clinical research. The collaboration combines Invivodata’s PRO consulting, technology, and service solutions with Quintiles’ comprehensive clinical services, to provide integrated processes and deliverables in an effort to reduce study complexity and cost throughout all phases of drug development. “Our collaboration with Invivodata will provide handheld t...